Diagnostic options · UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 2491–2505 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3792 TARDBP Gene Amyotrophic Lateral Sclerosis Type 10 Genetic Test This test evaluates the TARDBP gene for pathogenic variants associated with Amyotrophic Lateral Sclerosis Type 10 (ALS10). It uses Next Generation Sequencing (NGS) to analyze the e...	Peripheral Whole Blood	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TARDBP gene", "Single nucleotide variants", "Small insertions or deletions"] Parameters [] Preparation [] Indications ["Individuals with a family history of ALS", "Clinical suspicion of inherited motor neuron disease", "Early-onset motor weakness"] Measurement technique Confirm with laboratory Codes LOINC: 96231-1 ICD-10: G12.21 Clinical summary This test evaluates the TARDBP gene for pathogenic variants associated with Amyotrophic Lateral Sclerosis Type 10 (ALS10). It uses Next Generation Sequencing (NGS) to analyze the entire coding region and splice junctions.
TEST-4148 TARDBP Gene Frontotemporal Dementia Genetic Test This genetic test evaluates the TARDBP gene for pathogenic variants associated with frontotemporal dementia and amyotrophic lateral sclerosis.	Whole Blood (venous), Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TARDBP gene", "Single nucleotide variants", "Small insertions and deletions"] Parameters [] Preparation ["Pre-test genetic counseling session required.", "Detailed pedigree chart construction."] Indications ["Suspected frontotemporal dementia (FTD)", "Suspected amyotrophic lateral sclerosis (ALS)", "Family history of FTD or ALS", "Clarification of diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 92811-1 ICD-10: G31.09 Clinical summary This genetic test evaluates the TARDBP gene for pathogenic variants associated with frontotemporal dementia and amyotrophic lateral sclerosis.
TEST-5821 TAT Gene Tyrosinemia Type 2 (NGS) Genetic Test This test identifies pathogenic variants within the TAT gene, confirming or excluding a diagnosis of Tyrosinemia Type 2.	Whole Blood (EDTA), Extracted DNA, or FTA Card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TAT gene", "Coding exons and flanking intronic regions"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication or dietary therapy"] Indications ["Symptomatic individuals suspected of Tyrosinemia Type 2", "Carrier screening for at-risk family members", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 92643-2 ICD-10: E70.21, E70.20 Clinical summary This test identifies pathogenic variants within the TAT gene, confirming or excluding a diagnosis of Tyrosinemia Type 2.
TEST-4416 TAZ Gene Barth Syndrome Genetic Test This test evaluates the entire coding region and flanking intronic sequences of the TAZ gene using Next-Generation Sequencing (NGS). It detects pathogenic variants associated with...	Peripheral whole blood (EDTA) or dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TAZ gene sequence", "Copy number variations in TAZ gene", "Pathogenic variants (point mutations, insertions, deletions)"] Parameters [] Preparation ["No specific fasting required", "Continue all prescribed medications unless advised otherwise by your physician"] Indications ["Suspected Barth syndrome based on clinical presentation", "Family history of Barth syndrome", "Need for definitive genetic diagnosis for management and counseling"] Measurement technique Confirm with laboratory Codes LOINC: 83276-0 ICD-10: E88.8 Clinical summary This test evaluates the entire coding region and flanking intronic sequences of the TAZ gene using Next-Generation Sequencing (NGS). It detects pathogenic variants associated with Barth syndrome.
TEST-4236 TBC1D24 Gene (EIEE16) Next-Generation Sequencing DNA Test This test identifies pathogenic variants in the TBC1D24 gene associated with Early Infantile Epileptic Encephalopathy Type 16 (EIEE16), a severe neonatal seizure disorder.	Peripheral whole blood (EDTA tube) or FTA dried blood spot card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in TBC1D24 gene coding regions and intron-exon boundaries"] Parameters [] Preparation ["No specific patient preparation required"] Indications ["Diagnosis of Early Infantile Epileptic Encephalopathy Type 16 (EIEE16)", "Recurrence risk counseling for families with EIEE16"] Measurement technique Confirm with laboratory Codes LOINC: 21649-1 ICD-10: G40.4 Clinical summary This test identifies pathogenic variants in the TBC1D24 gene associated with Early Infantile Epileptic Encephalopathy Type 16 (EIEE16), a severe neonatal seizure disorder.
TEST-5730 TBC1D24 Gene Autosomal Dominant Deafness Type 65 (DFNA65) Genetic Test This test identifies pathogenic variants in the TBC1D24 gene associated with autosomal dominant nonsyndromic hearing loss type DFNA65.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TBC1D24 gene"] Parameters [] Preparation ["No special preparation required", "Do not discontinue prescribed medications without physician approval"] Indications ["Suspected autosomal dominant nonsyndromic hearing loss (DFNA65)", "Genetic counseling for families with hearing loss"] Measurement technique Confirm with laboratory Codes LOINC: 82111-3 ICD-10: Z13.71, H90.3, Z82.2 Clinical summary This test identifies pathogenic variants in the TBC1D24 gene associated with autosomal dominant nonsyndromic hearing loss type DFNA65.
TEST-5590 TBC1D24 Gene Deafness, Autosomal Recessive Type 86 Genetic Test This genetic test evaluates the TBC1D24 gene for pathogenic variants associated with autosomal recessive nonsyndromic hearing loss type 86 (DFNB86).	Peripheral Whole Blood (EDTA)	3–4 weeks (21–28 business days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TBC1D24 gene", "Coding exons, splice sites, and exon-intron boundaries of TBC1D24"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Diagnosis of autosomal recessive nonsyndromic hearing loss type 86 (DFNB86)", "Genetic counseling for families with hearing loss", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 82236-1 ICD-10: H90.3, Z13.71 Clinical summary This genetic test evaluates the TBC1D24 gene for pathogenic variants associated with autosomal recessive nonsyndromic hearing loss type 86 (DFNB86).
TEST-2869 TBC1D24 Gene DOOR Syndrome Genetic Test This test identifies pathogenic variants in the TBC1D24 gene associated with DOOR syndrome.	Peripheral Whole Blood, Dried Blood Spot (FTA Card), or Pre-extracted DNA	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in TBC1D24 gene", "Full gene coverage"] Parameters [] Preparation ["Pre-test genetic counseling is mandatory"] Indications ["Individuals with clinical features suggestive of DOOR syndrome", "Family members of individuals with DOOR syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q87.8 Clinical summary This test identifies pathogenic variants in the TBC1D24 gene associated with DOOR syndrome.
TEST-5862 TBP Gene Spinocerebellar Ataxia Type 17 (SCA17), Autosomal Dominant, Genetic Test This genetic test identifies pathogenic variants in the TBP gene associated with Spinocerebellar Ataxia Type 17 (SCA17). It provides a definitive molecular diagnosis for this autos...	Whole Blood (EDTA tube) or FTA card (capillary blood spot)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TBP gene", "Causative mutations for SCA17"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Diagnosis of suspected SCA17", "Predictive testing for individuals with a family history of SCA17", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 80862-0 ICD-10: G11.8 Clinical summary This genetic test identifies pathogenic variants in the TBP gene associated with Spinocerebellar Ataxia Type 17 (SCA17). It provides a definitive molecular diagnosis for this autosomal dominant neurodegenerative disorder.
TEST-2873 TBX1 Gene DiGeorge Syndrome Genetic Test This test evaluates the TBX1 gene for pathogenic variants associated with DiGeorge syndrome.	Peripheral Whole Blood (3–5 mL in EDTA tube); also accepts extracted genomic DNA (≥1 µg) or FTA card blood spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants in TBX1", "Small insertions and deletions in TBX1", "Copy number alterations in TBX1 at exon-level resolution"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Individuals with clinical features suggestive of DiGeorge syndrome", "Family history of DiGeorge syndrome", "Confirmation of diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 93936-1 ICD-10: D82.1 Clinical summary This test evaluates the TBX1 gene for pathogenic variants associated with DiGeorge syndrome.
TEST-2939 TBX15 Gene Cousin Syndrome Genetic Test This genetic test detects pathogenic and likely pathogenic variants in the T-box 15 gene associated with Cousin syndrome.	Peripheral Whole Blood / DNA (FTA Card acceptable)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TBX15 gene", "Single nucleotide variants", "Small insertions and deletions", "Copy number alterations"] Parameters [] Preparation ["No fasting or dietary restrictions are needed"] Indications ["Clinical suspicion of Cousin syndrome", "Family history of Cousin syndrome", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 55221-3 ICD-10: Q87.8 Clinical summary This genetic test detects pathogenic and likely pathogenic variants in the T-box 15 gene associated with Cousin syndrome.
TEST-3935 TBX19 Gene Adrenocorticotropic Hormone Deficiency Genetic Test This genetic test identifies pathogenic variants in the TBX19 gene associated with congenital isolated ACTH deficiency.	Whole Blood or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TBX19 gene"] Parameters [] Preparation [] Indications ["Suspected congenital isolated ACTH deficiency", "Family history of ACTH deficiency"] Measurement technique Confirm with laboratory Codes LOINC: 94083-0 ICD-10: E23.0 Clinical summary This genetic test identifies pathogenic variants in the TBX19 gene associated with congenital isolated ACTH deficiency.
TEST-1088 TBX5 Full-Length Gene Sequence Analysis (Holt-Oram Syndrome) Test This test analyzes the entire coding region of the TBX5 gene to identify mutations associated with Holt-Oram syndrome.	Peripheral Blood or Prenatal Specimen (Amniotic Fluid, Chorionic Villi, Cord Blood)	4–6 weeks	5,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TBX5 gene sequence", "Pathogenic variants in TBX5"] Parameters [] Preparation [] Indications ["Individuals with clinical features suggestive of Holt-Oram syndrome", "At-risk family members", "Prenatal diagnosis when a familial mutation is known"] Measurement technique Confirm with laboratory Codes LOINC: 77130-7 ICD-10: Q87.2, Z82.79, Z13.79 Clinical summary This test analyzes the entire coding region of the TBX5 gene to identify mutations associated with Holt-Oram syndrome.
TEST-2739 TBX5 Gene Holt-Oram Syndrome Genetic Test This genetic test analyzes the TBX5 gene to detect variants associated with Holt-Oram syndrome.	Whole blood (EDTA tube), extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variations (CNVs)", "Deep intronic variants"] Parameters [] Preparation [] Indications ["Suspected Holt-Oram syndrome based on clinical presentation", "Family history of Holt-Oram syndrome", "Genetic counselling for individuals with relevant clinical features"] Measurement technique Confirm with laboratory Codes LOINC: 100267-2 ICD-10: Q87.2 Clinical summary This genetic test analyzes the TBX5 gene to detect variants associated with Holt-Oram syndrome.
TEST-2279 TBX6 Gene Spondylocostal Dysostosis Type 5 Genetic Test This test identifies pathogenic variants or copy number variations in the TBX6 gene associated with Spondylocostal Dysostosis Type 5.	Whole blood (3–5 mL in EDTA), extracted DNA (1–2 µg), or FTA card blood spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TBX6 gene sequence", "Copy Number Variations (CNV) in TBX6"] Parameters [] Preparation ["Pre-test genetic counseling session is mandatory", "Obtain written informed consent"] Indications ["Clinical or radiological features of spondylocostal dysostosis", "Establish a definitive molecular diagnosis", "Guide family counseling"] Measurement technique Confirm with laboratory Codes LOINC: 81205-9 ICD-10: Q76.4 Clinical summary This test identifies pathogenic variants or copy number variations in the TBX6 gene associated with Spondylocostal Dysostosis Type 5.

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Genetics tests in Dubai & UAE

Genetics test prices

Genetics: overview

Use the test details as a conversation starter

Related Genetics categories